Xunlei Limited Schedules 2025 Unaudited Second Quarter Earnings Release on August 14, 2025

Xunlei Limited Schedules 2025 Unaudited Second Quarter Earnings Release on August 14, 2025 GlobeNewswire August 07, 2025 SHENZHEN, China, Aug. 07, 2025 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced that it plans to release its unaudited financial results for […]

Milestone Achievement for Hospital Using Catheter Precision’s VIVO System

Milestone Achievement for Hospital Using Catheter Precision's VIVO System Heart Hospital of New Mexico is the First Hospital to Complete 200 Ventricular Ablation Procedures with the VIVO System GlobeNewswire August 07, 2025 FORT MILL, S.C., Aug. 07, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on

Nualtis Announces Strategic Partnership with OrthoNu for Innovative Orthodontic Care Products

Nualtis Announces Strategic Partnership with OrthoNu for Innovative Orthodontic Care Products GlobeNewswire August 07, 2025 MONTREAL, Aug. 07, 2025 (GLOBE NEWSWIRE) — Nualtis (formerly IntelGenx Corp.), a leader in oral film drug delivery technologies, today announced a strategic partnership with OrthoNu LLC to develop and manufacture an innovative portfolio of oral thin-film orthodontic and dentistry

Route 92 Medical Files Patent Infringement Suit Against Balt

Route 92 Medical Files Patent Infringement Suit Against Balt GlobeNewswire August 07, 2025 SAN MATEO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, filed a patent infringement lawsuit against Balt USA, LLC (Balt) alleging infringement of five

Maxus Mining Initiates 2025 Exploration Program on the Penny Copper Project, British Columbia

Maxus Mining Initiates 2025 Exploration Program on the Penny Copper Project, British Columbia GlobeNewswire August 07, 2025 VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — Maxus Mining Inc. (“Maxus” or the “Company“) (CSE: MAXM | FRA: R7V), is pleased to announce the commencement of the Company's 2025 exploration program (the “Program“) on its Penny

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 GlobeNewswire August 07, 2025 DURHAM, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the quarter ended June

Geotab at 25: Driving the Future of Connected Vehicles

Geotab at 25: Driving the Future of Connected Vehicles From the spark of an idea to global impact: A quarter-century of innovation fueled by data insights and collaboration GlobeNewswire August 07, 2025 OAKVILLE, Ontario, Aug. 07, 2025 (GLOBE NEWSWIRE) — Today, Geotab marks its 25th anniversary, celebrating remarkable global growth, pioneering AI driven innovation, and

Top Pet Innovators Unleashed in 2025 Pet Innovation Awards

Top Pet Innovators Unleashed in 2025 Pet Innovation Awards Annual Awards Program Recognizes Companies, Services And Products Within The Rapidly Expanding Pet Industry That Exemplify Excellence & Innovation GlobeNewswire August 07, 2025 LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) — The 2025 Pet Innovation Awards, an independent recognition platform highlighting innovative companies, services, and products

Super League Sets Second Quarter 2025 Earnings Date, August 14, 2025

Super League Sets Second Quarter 2025 Earnings Date, August 14, 2025 GlobeNewswire August 07, 2025 SANTA MONICA, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE), a leader in engaging audiences through playable media, content, and experiences within mobile games and the world's largest immersive platforms, announced today that the Company will post

RAPT Therapeutics Reports Second Quarter 2025 Financial Results

RAPT Therapeutics Reports Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today reported financial

Scroll to Top